DM
Dara K. Mohammad
Research areas: Medicine · Public Health, Environmental and Occupational Health · Global Health and Epidemiology · Healthcare Systems and Public Health · Cardiovascular Health and Risk Factors
0000-0001-9201-0991
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (37)
- Association Between Natural Killer Cell Subsets (CD56bright and CD56dim) and Infectious Complications in Newly Diagnosed Multiple Myeloma (NDMM) Patients Save
- Molecular Analysis of miR-155 and MIR155HG Mutations in Conjunction with TLR4 Variants in Inflammatory Joint Disease Save
- Association of Vitamin D Receptor (VDR) Gene Polymorphisms with COVID-19 Susceptibility in the Kurdistan Region Save
- Astrocyte-neuron mitochondrial transfer via mitoEVs supports neuronal energy metabolism and is impaired in early Alzheimer’s disease Save
- Antibody-displaying extracellular vesicles for targeted cancer therapy Save
- Tumor cell derived osteopontin and prostaglandin E2 synergistically promote the expansion of myeloid derived suppressor cells during the tumor immune escape phase Save
- Tumor cell derived osteopontin and prostaglandin E2 synergistically promote the expansion of myeloid derived suppressor cells during the tumor immune escape phase Save
- Tumor cell derived osteopontin and prostaglandin E2 synergistically promote the expansion of myeloid derived suppressor cells during the tumor immune escape phase Save
- SHP-1 localization to the activating immune synapse promotes NK cell tolerance in MHC class I deficiency Save
- Assessment of T Cell Receptor Complex Expression Kinetics in Natural Killer Cells Save
- BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib Save
- Short-term IL-15 priming leaves a long-lasting signalling imprint in mouse NK cells independently of a metabolic switch Save
- BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib Save
- BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib Save
- Five insights from the Global Burden of Disease Study 2019. Save
- Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Save
- The status of cancer publications in the Kurdistan region of Iraq Save
- The kidney injury caused by the onset of acute graft-versus-host disease is associated with down-regulation of αKlotho. Save
- Mapping 123 million neonatal, infant and child deaths between 2000 and 2017. Save
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. Save